Acuity Investment Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$83K Sell
2,530
-527
-17% -$16.8K 0.12% 122
2014
Q4
$90K Hold
3,057
0.07% 125
2014
Q3
$86K Sell
3,057
-1,264
-29% -$35.5K 0.07% 123
2014
Q2
$122K Sell
4,321
-28,669
-87% -$817K 0.08% 125
2014
Q1
$1M Sell
32,990
-46,060
-58% -$1.37M 0.55% 46
2013
Q4
$2.3M Sell
79,050
-224,397
-74% -$6.53M 0.91% 29
2013
Q3
$8.25M Sell
303,447
-106,348
-26% -$2.89M 1.13% 18
2013
Q2
$10.9M Buy
+409,795
New +$11.3M 1.4% 15

Other funds holding PFE

Acuity Investment Management's PFE Position: Q1 2015 in Review

Acuity Investment Management reduced its Pfizer (PFE) stake by 17% in Q1 2015, selling an estimated $16.8K and leaving 2,530 shares worth $83K. The position accounts for 0.12% of the portfolio, ranked #122.

Acuity Investment Management first reported a position in PFE in Q2 2013 and has held it in 8 quarters since. The position peaked at $10.9M in Q2 2013. 1,877 funds tracked by Wall St. Rank hold PFE as of Q1 2015.

  • Acuity Investment Management held 2,530 shares of Pfizer worth $83K as of Q1 2015.
  • Acuity Investment Management sold 527 Pfizer shares in Q1 2015, an estimated $16.8K.
  • Pfizer made up 0.12% of Acuity Investment Management's portfolio in Q1 2015, its #122 holding.
  • Acuity Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 8 quarters since.
  • Acuity Investment Management's Pfizer position peaked at $10.9M in Q2 2013.
  • 1,877 funds tracked by Wall St. Rank held Pfizer as of Q1 2015.

Based on Acuity Investment Management's 13F filing for Q1 2015, filed 11 May 2015.